- Sales Revenue of $15m
- Statutory Net Profit After Tax up 47% to $2.4m from $1.6m
- Adjusted Profit Before Tax* up 4% to $2.4m from $2.3m
*Adjusted Profit Before Tax is after adding back/deducting items related to COVID-19. A full break-down of these items is available in the Half-Year Report.
CCZ has a "Buy" call on XRF and a TP (target price) of 31 cps (cents per share).
--- click on link at the top for the full report ---
17-Apr-2020: XRF Scientific March 2020 Quarterly Trading Report
Market like! XRF were up to as high as 22 cps (+33%) earlier today, and they're still up at 19.5 cps (up 3c or +18.2%) on the back of this report. They had peaked at 26.5c on Feb 21, then dropped -47% in 4 weeks to close at 14c on March 24. So far, they've climbed about half way back up.